TORONTO, Sept. 23, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, announced today that the company is scheduled to present at the Fifth Annual JMP Securities Healthcare Conference, Monday, September 27, 2010, at 3:30 p.m. Eastern Time in New York City. Dr. Isa Odidi, Chief Executive Officer of Intellipharmaceutics, will provide a company overview. The conference presentation will be webcast live and accessible at Intellipharmaceutics’ website under Investor Relations / Events and Presentations, and will be archived there following the presentation. Please connect to Intellipharmaceutics’ website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
